In the future, such an approach could be harnessed to rescue expression of CEBPA or other regulators of aberrant epithelial cell types in patients with IPF and other chronic lung diseases, to restore tissue homeostasis and promote lung repair. The gene discussed is CEBPA; the disease is chronic lung disease.